array:24 [ "pii" => "S2387020624001499" "issn" => "23870206" "doi" => "10.1016/j.medcle.2023.11.023" "estado" => "S300" "fechaPublicacion" => "2024-05-17" "aid" => "6521" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2024;162:455-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775324000095" "issn" => "00257753" "doi" => "10.1016/j.medcli.2023.11.029" "estado" => "S300" "fechaPublicacion" => "2024-05-17" "aid" => "6521" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2024;162:455-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Trombosis venosa portal asociada a infección aguda por citomegalovirus" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "455" "paginaFinal" => "456" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Portal venous thrombosis associated with acute cytomegalovirus infection" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Luigina Maureen Ron Astudillo, Javier Pérez Stachowski, Ángeles Pérez Aisa" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Luigina Maureen" "apellidos" => "Ron Astudillo" ] 1 => array:2 [ "nombre" => "Javier" "apellidos" => "Pérez Stachowski" ] 2 => array:2 [ "nombre" => "Ángeles" "apellidos" => "Pérez Aisa" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020624001499" "doi" => "10.1016/j.medcle.2023.11.023" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624001499?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775324000095?idApp=UINPBA00004N" "url" => "/00257753/0000016200000009/v1_202405080526/S0025775324000095/v1_202405080526/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020624001505" "issn" => "23870206" "doi" => "10.1016/j.medcle.2023.11.024" "estado" => "S300" "fechaPublicacion" => "2024-05-17" "aid" => "6527" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2024;162:456-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Role of plasma exchange in myasthenia gravis in the shortage of immunoglublins" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "456" "paginaFinal" => "457" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Papel del recambio plasmástico en el abordaje de la miastenia gravis ante el desabastecimiento de inmunoglobulinas" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ingrid Magnolia Parra Salinas, José Antonio García Erce" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Ingrid Magnolia" "apellidos" => "Parra Salinas" ] 1 => array:2 [ "nombre" => "José Antonio" "apellidos" => "García Erce" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775324000083" "doi" => "10.1016/j.medcli.2023.11.033" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775324000083?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624001505?idApp=UINPBA00004N" "url" => "/23870206/0000016200000009/v2_202405200151/S2387020624001505/v2_202405200151/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S238702062400144X" "issn" => "23870206" "doi" => "10.1016/j.medcle.2023.10.027" "estado" => "S300" "fechaPublicacion" => "2024-05-17" "aid" => "6491" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2024;162:448-54" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "The value of vaccines in the 21st century" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "448" "paginaFinal" => "454" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El valor de las vacunas en el siglo XXI" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:9 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Source: Author’s own." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2319 "Ancho" => 3452 "Tamanyo" => 467807 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Classical classification of vaccines.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Irma Casas, Karen Colmenares, Beatriz Blanco, Julia Valera" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Irma" "apellidos" => "Casas" ] 1 => array:2 [ "nombre" => "Karen" "apellidos" => "Colmenares" ] 2 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Blanco" ] 3 => array:2 [ "nombre" => "Julia" "apellidos" => "Valera" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775323007091" "doi" => "10.1016/j.medcli.2023.10.025" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323007091?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S238702062400144X?idApp=UINPBA00004N" "url" => "/23870206/0000016200000009/v2_202405200151/S238702062400144X/v2_202405200151/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Portal venous thrombosis associated with acute cytomegalovirus infection" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "455" "paginaFinal" => "456" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Luigina Maureen Ron Astudillo, Javier Pérez Stachowski, Ángeles Pérez Aisa" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Luigina Maureen" "apellidos" => "Ron Astudillo" "email" => array:1 [ 0 => "ronluigina@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Javier" "apellidos" => "Pérez Stachowski" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Ángeles" "apellidos" => "Pérez Aisa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Costa del Sol, Málaga, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Aparato Digestivo, Hospital Costa del Sol, Málaga, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Trombosis venosa portal asociada a infección aguda por citomegalovirus" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Cytomegalovirus (CMV) is a DNA virus that belongs to the <span class="elsevierStyleItalic">Herpesviridae</span> family. Can cause acute infection and remain latent in the host.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Seroprevalence is estimated at 83% varying by geographic area, race and age.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> It is usually asymptomatic or causes a mononucleosis syndrome in immunocompetent individuals, whereas severe disseminated manifestations are more common in immunocompromised individuals.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In the present case, venous thrombosis developed as an atypical manifestation associated with acute CMV infection. It has an incidence of 6.4% and, although infection is most common during childhood or young adulthood, thrombotic events are most prevalent between the ages of 25 and 55.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">A 34-year-old male, immunocompetent and with no relevant personal history, presented with a fever of 39.5 °<span class="elsevierStyleSmallCaps">C</span>, mostly in the evenings, accompanied by profuse sweating of 2 week’s duration. It did not improve despite the use of antipyretics and after seven days of treatment with cefuroxime. He had been experiencing discontinuous abdominal pain for four months, mainly in the right iliac fossa, with periods of three or four diarrhoeal stools per day without pathological products. He had not started new medication and had not had any recent surgery. Nor had she travelled abroad or remembered any insect bites.</p><p id="par0020" class="elsevierStylePara elsevierViewall">On physical examination he was conscious, oriented, well hydrated and perfused. No palpation of cervical, supraclavicular, axillary or inguinal lymph nodes. No pathological findings on cardiopulmonary auscultation. The abdomen was soft with discomfort on palpation in the epigastrium and right iliac fossa. No masses, lymphadenopathy, limb oedema or skin lesions were detected. He exhibited preserved mobility and overall strength.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Blood tests showed glutamate oxaloacetate transaminase (GOT) 95 U/L, glutamate pyruvate transaminase (GPT) 153 U/L, alkaline phosphatase 91 U/L, lactate dehydrogenase 423 U/L, total bilirubin 0.7 mg/dL, procalcitonin 0.28 ng/mL and C-reactive protein 55 mg/L. The CBC showed 6550 WBCs/μL, (32.8% lymphocytes/μL), 166,000 platelets/μL y 15 g/dL haemoglobin. The coagulation and hypercoagulability study (antiphospholipid antibodies, proteins C and S, antithrombin and factor II mutation) was normal. His immunoglobulin M (IgM) levels were 236 mg/dL (normal 40–230 mg/dL) and beta-2-microglobulin 7.16 mg/L (normal 0.7–1.8 mg/L). The study of tumour markers (including carcinoembryonic antigen [CEA], cancer antigens 15.3 [CA15.3], 125 [CA125] and 19.9 [CA19.9], prostate-specific antigen [PSA] and alpha-fetoprotein [AFP]), autoimmunity (anti-nuclear antibodies, anti-DNA, anti-mitochondrial, anti-smooth muscle [ASMA], antibodies against liver and kidney microsomes (LKM), parietal cell antibodies), and serology for <span class="elsevierStyleItalic">Coxiella, Brucella, Rickettsia, Bartonella</span>, syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) were negative. He showed immunoglobulin G (IgG) antibodies to Epstein–Barr virus and IgM antibodies to CMV at a titre higher than 1:8, so serum viral load was determined (1733 IU/mL). Blood cultures, urine cultures and stool cultures on different days were negative. An abdominal ultrasound was performed showing a diffuse increase in hepatic echogenicity, low <span class="elsevierStyleItalic">doppler</span> uptake in the right portal vein and splenomegaly with a major axis of 16 cm. Upper and lower gastrointestinal endoscopy and echocardiography were performed without findings of interest. Abdominal computed tomography (CT) confirmed right portal branch thrombosis and positron emission tomography (PET/CT) showed increased splenic reactive uptake, with no other pathological findings.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Rivaroxaban was prescribed at a dose of 15 mg every 12 h for 21 days and thereafter 20 mg daily until completion of six months of treatment. Within two weeks of hospital discharge, symptoms had subsided, and acute phase reactants and liver profile returned to normal. A follow-up abdominal CT scan at 3 months showed resolution of the thrombosis.</p><p id="par0035" class="elsevierStylePara elsevierViewall">CMV promotes a procoagulant state by inducing the release of von Willebrand factor at the endothelial level, increasing tissue factor expression on the cell surface, and inhibiting antithrombin III and fibrinolysis. Phospholipids in its envelope trigger an immune response that reduces Factor Xa clotting time by directly activating thrombin.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,3</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">A systematic review of 115 cases found that the most common sites were the pulmonary arteries (25.7%), portal (23.4%), splenic (13.9%) and superior mesenteric (13.5%) veins.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The risk increases when other factors coexist such as thrombophilia (antiphospholipid antibodies; mutation of factor V Leiden, factor II, VIII or mutation of the methylenetetrahydrofolate reductase gene [<span class="elsevierStyleItalic">MTHFR</span>]; protein C and S deficiencies, and hyperhomocysteinemia), advanced age, pregnancy, oestrogen therapy, prolonged immobilisation, previous episodes or neoplastic disease.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Antiviral treatment has only been shown to be cost-effective in immunocompromised individuals and, although there is no consensus on anticoagulation, it is recommended for at least three months in the absence of other risk factors.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,5</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0050" class="elsevierStylePara elsevierViewall">This work has not received any funding.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflict of interest</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflict of interest" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cytomegalovirus-associated thrombosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.I.M. Neppelenbroek" 1 => "P.A. Rootjes" 2 => "L. Boxhoorn" 3 => "J.F.P. Wagenaar" 4 => "S. Simsek" 5 => "F. Stam" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neth J Med" "fecha" => "2018" "volumen" => "76" "paginaInicial" => "251" "paginaFinal" => "254" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30019682" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Zuhair" 1 => "G.S.A. Smit" 2 => "G. Wallis" 3 => "F. Jabbar" 4 => "C. Smith" 5 => "B. Devleesschauwer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/rmv.2034" "Revista" => array:5 [ "tituloSerie" => "Rev Med Virol" "fecha" => "2019" "volumen" => "29" "paginaInicial" => "e2034" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30706584" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cytomegalovirus (CMV)-associated portal vein thrombosis in a healthy, immunocompetent man" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Burkey" 1 => "C. Teng" 2 => "K.I. Hussein" 3 => "J. Sabetta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bcr-2020-238645" "Revista" => array:5 [ "tituloSerie" => "BMJ Case Rep" "fecha" => "2020" "volumen" => "13" "paginaInicial" => "e238645" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33372022" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Ceccarelli" 1 => "E. Venanzi Rullo" 2 => "G. Nunnari" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10096-018-3185-y" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Microbiol Infect Dis" "fecha" => "2018" "volumen" => "37" "paginaInicial" => "381" "paginaFinal" => "390" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29344839" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cytomegalovirus-associated venous and arterial thrombotic disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.H. Kelkar" 1 => "B.L. Loc" 2 => "M.D. Tarantino" 3 => "A. Rajasekhar" 4 => "H. Wang" 5 => "M. Kelkar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7759/cureus.12161" "Revista" => array:5 [ "tituloSerie" => "Cureus" "fecha" => "2020" "volumen" => "12" "paginaInicial" => "e12161" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33489573" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000016200000009/v2_202405200151/S2387020624001499/v2_202405200151/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000016200000009/v2_202405200151/S2387020624001499/v2_202405200151/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624001499?idApp=UINPBA00004N" ]
Journal Information
Vol. 162. Issue 9.
Pages 455-456 (May 2024)
Share
Download PDF
More article options
Vol. 162. Issue 9.
Pages 455-456 (May 2024)
Letter to the Editor
Portal venous thrombosis associated with acute cytomegalovirus infection
Trombosis venosa portal asociada a infección aguda por citomegalovirus
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail